Cure.AI: The AI Healthcare Vision

Global Growth and Milestones

Founders and Origin Story

Reinventing Medical Diagnostics

Early Detection and Cost Impact

Revenue Model and Funding

Competition and Market Edge

India’s Adoption Challenge

What’s Next for Cure.AI

Data Privacy and AI Learning

Final Takeaways

Qure.ai is transforming routine medical imaging into early disease detection at unprecedented scale. Processing nearly 1,000 patients per hour across 105 countries, the startup has made preliminary radiology reports at India’s AIIMS and CMC Vellore AI-powered often flagging diseases physicians weren’t even looking for. In this conversation, Vikas Dandekar speaks with Prashant Warier Co-founder & CEO, Ankit Modi, Founding Member and Chief Product Officer and Preetham Putha, Founding Member and Chief AI Officer about how Qure.ai is reimagining diagnostics. Their breakthrough includes risk-scoring algorithms that detect high-risk lung nodules on standard chest X-rays, achieving a 54% CT-confirmed malignancy rate. From TB screening programs in Mumbai. where their tools uncovered 35% more cases for lung cancer detection in US hospitals, Qure.ai now holds 19 FDA clearances and WHO endorsement for autonomous AI diagnosis. Founded in 2016 and trained on over 1.5 billion anonymized images, Qure.ai has published clinical evidence in The Lancet and Nature. With current revenues of ₹200 crore, the company is targeting profitability within two years while scaling toward its ambition of impacting 1 billion lives by 2030.

Qure.ai is transforming routine medical imaging into early disease detection at unprecedented scale. Processing nearly 1,000 patients per hour across 105 countries, the startup has made preliminary radiology reports at India&rsquo;s AIIMS and CMC Vellore AI-powered often flagging diseases physicians weren&rsquo;t even looking for. In this conversation, Vikas Dandekar speaks with Prashant Warier Co-founder &amp; CEO, Ankit Modi, Founding Member and Chief Product Officer and Preetham Putha, Founding Member and Chief AI Officer about how Qure.ai is reimagining diagnostics. Their breakthrough includes risk-scoring algorithms that detect high-risk lung nodules on standard chest X-rays, achieving a 54% CT-confirmed malignancy rate. From TB screening programs in Mumbai. where their tools uncovered 35% more cases for lung cancer detection in US hospitals, Qure.ai now holds 19 FDA clearances and WHO endorsement for autonomous AI diagnosis. Founded in 2016 and trained on over 1.5 billion anonymized images, Qure.ai has published clinical evidence in The Lancet and Nature. With current revenues of ₹200 crore, the company is targeting profitability within two years while scaling toward its ambition of impacting 1 billion lives by 2030.

Corner Office Conversation is The Economic Times’ flagship interview podcast featuring unfiltered, one-on-one conversations with some of India and the world’s most powerful business leaders.

Hosted by ET’s top journalists and editors, this fortnightly show goes beyond headlines and press releases to explore how CEOs and founders think, decide, and lead in an era of disruption.

From Marc Benioff (Salesforce), Dara Khosrowshahi (Uber), and Roland Busch (Siemens) to Adar Poonawalla (Serum Institute), Suresh Narayanan (Nestlé India), and Ravi Kumar S (Cognizant), these conversations uncover personal leadership playbooks, global strategy pivots, lessons from failures, and bold visions for the future — across industries like tech, healthcare, manufacturing, finance, and consumer goods.

New episodes drop every alternate Monday.

Corner Office Conversation is The Economic Times&rsquo; flagship interview podcast featuring unfiltered, one-on-one conversations with some of India and the world&rsquo;s most powerful business leaders.
Hosted by ET&rsquo;s top journalists and editors, this fortnightly show goes beyond headlines and press releases to explore how CEOs and founders think, decide, and lead in an era of disruption.
From Marc Benioff (Salesforce), Dara Khosrowshahi (Uber), and Roland Busch (Siemens) to Adar Poonawalla (Serum Institute), Suresh Narayanan (Nestl&eacute; India), and Ravi Kumar S (Cognizant), these conversations uncover personal leadership playbooks, global strategy pivots, lessons from failures, and bold visions for the future &mdash; across industries like tech, healthcare, manufacturing, finance, and consumer goods.
New episodes drop every alternate Monday.